日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dual association patterns between microglial activation and neuronal health in Alzheimer's disease: a whole-brain MRSI/PET study

阿尔茨海默病中小胶质细胞活化与神经元健康之间的双重关联模式:一项全脑磁共振波谱成像/正电子发射断层扫描研究

Zhang, Yaoyu; Qian, Xiao-Hang; Zhuang, Huixiang; Zhang, Wenqi; Hu, Jialin; Zhao, Yibo; Li, Yudu; Jin, Wen; Xu, Chang; Meng, Ziyu; Li, Wenli; Chen, Siyue; Jiang, Xu-Feng; Guo, Tengfei; Li, Ya-Dong; Ye, Jian; Liang, Zhi-Pei; Li, Biao; Zhang, Miao; Tang, Huidong; Li, Yao

A phase 2 study of zanubrutinib in combination with rituximab and lenalidomide in de novo diffuse large B-cell lymphoma.

一项针对新发弥漫性大B细胞淋巴瘤的 2 期研究,评估 zanubrutinib 与利妥昔单抗和来那度胺联合用药的疗效。

Xu Peng-Peng, Zhu Yue, Shi Zi-Yang, Wang Li, Cheng Shu, Qian Ying, Zhao Yan, He Yang, Yi Hong-Mei, Ou-Yang Bin-Shen, Jiang Xu-Feng, Li Biao, Song Qi, Mu Rong-Ji, Zhao Wei-Li

Associations between Aβ deposition and neurometabolic alterations in Alzheimer's disease: Insights from hybrid 3D MRSI-PET imaging

阿尔茨海默病中Aβ沉积与神经代谢改变之间的关联:来自混合3D MRSI-PET成像的启示

Zhang, Miao; Hu, Jialin; Zhang, Yaoyu; Meng, Ziyu; Zhao, Yibo; Li, Yudu; Jin, Wen; Qian, Xiao-Hang; Wang, Lijun; Ye, Guanyu; Jiang, Xu-Feng; Li, Ya-Dong; Ye, Jian; Tang, Huidong; Liu, Jun; Nachev, Parashkev; Liang, Zhi-Pei; Li, Biao; Li, Yao

Response-adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T-cell therapy in relapsed/refractory large B-cell lymphoma: A retrospective observational study.

反应适应性 zanubrutinib 和 tislelizumab 作为增强 CD19 CAR T 细胞疗法治疗复发/难治性大 B 细胞淋巴瘤的潜在策略:一项回顾性观察研究

Shen Rong, Cao Wei-Guo, Wang Li, Sheng Ling-Shuang, Zhang Yi-Lun, Wu Wen, Xu Peng-Peng, Cheng Shu, Liu Meng-Ke, Dong Yan, Wang Yue, Weng Xiang-Qin, Jiang Xu-Feng, Song Qi, Yi Hong-Mei, Li Lei, Chen Sheng, Yan Zi-Xun, Zhao Wei-Li

Baseline total lesion glycolysis identifies high-risk patients with immunosuppressive signatures in early-stage natural killer/T-cell lymphoma

基线总病灶糖酵解可识别早期自然杀伤/T细胞淋巴瘤中具有免疫抑制特征的高危患者

Gao, Xiao; Xiong, Jie; Huang, Xin-Yun; Yang, Hao-Xu; Zhong, Hui-Juan; Cheng, Shu; Jiang, Xu-Feng; Zhao, Wei-Li

Different Role of PET-CT Evaluation in Newly Diagnosed Follicular Lymphoma Upon Rituximab-Based Chemotherapy and Chemo-Free Immunotherapy

PET-CT评估在接受利妥昔单抗化疗和无化疗免疫治疗的新诊断滤泡性淋巴瘤中的不同作用

Wang, Nan; Huang, Xin-Yun; Jiang, Xu-Feng; Wang, Li; Cheng, Shu; Xu, Peng-Peng; Dong, Lei; Ou-Yang, Bin-Shen; Mu, Rong-Ji; Li, Chen; Zhao, Yan; Feng, Yan; Dou, Hong-Jing; Zheng, Zhong; Zhao, Wei-Li

18F-FDG PET/CT metrics-based stratification of large B-cell lymphoma receiving CAR-T cell therapy: immunosuppressive tumor microenvironment as a negative prognostic indicator in patients with high tumor burden

基于18F-FDG PET/CT指标对接受CAR-T细胞治疗的大B细胞淋巴瘤患者进行分层:免疫抑制性肿瘤微环境是高肿瘤负荷患者的负性预后指标

Sheng, Ling-Shuang; Shen, Rong; Yan, Zi-Xun; Wang, Chao; Zheng, Xin; Zhang, Yi-Lun; Yang, Hao-Xu; Wu, Wen; Xu, Peng-Peng; Cheng, Shu; Bachy, Emmanuel; Sesques, Pierre; Jacquet-Francillon, Nicolas; Jiang, Xu-Feng; Zhao, Wei-Li; Wang, Li

Comprehensive analysis of next generation sequencing and ARMS-PCR for detecting EGFR exon 20 insertion (ex20ins) mutations in Chinese non-small cell lung cancer patients

新一代测序和ARMS-PCR综合分析检测中国非小细胞肺癌患者EGFR外显子20插入(ex20ins)突变

Yuyin Xu #, Liqing Jia #, Ling Zhang #, Haochen Wang, Lin Jiang, Xu Feng, Ran Wei, Qianlan Yao, Min Ren, Tian Xue, Yuan Li, Xiaoli Zhu, Xiaoyan Zhou, Qianming Bai

Positron emission tomography-adapted therapy in low-risk diffuse large B-cell lymphoma: results of a randomized, phase III, non-inferiority trial

正电子发射断层扫描指导的低危弥漫性大B细胞淋巴瘤治疗:一项随机、III期、非劣效性试验的结果

Shi, Qing; He, Yang; Yi, Hong-Mei; Mu, Rong-Ji; Jiang, Xu-Feng; Fu, Di; Dong, Lei; Qin, Wei; Xu, Peng-Peng; Cheng, Shu; Song, Qi; Chen, Sai-Juan; Wang, Li; Zhao, Wei-Li

Clinical efficacy and tumour microenvironment influence of decitabine plus R-CHOP in patients with newly diagnosed diffuse large B-Cell lymphoma: Phase 1/2 and biomarker study

地西他滨联合R-CHOP方案治疗新诊断弥漫性大B细胞淋巴瘤患者的临床疗效及肿瘤微环境影响:I/II期临床试验及生物标志物研究

Zhang, Mu-Chen; Fang, Ying; Xu, Peng-Peng; Dong, Lei; Shen, Rong; Huang, Yao-Hui; Fu, Di; Yan, Zi-Xun; Cheng, Shu; Jiang, Xu-Feng; Song, Qi; He, Yang; Zhao, Yan; Lu, Min; Ye, Jing; Liu, Feng; Cheng, Lin; Wang, Chao-Fu; Wang, Li; Zhao, Wei-Li